
Priscilla Ying Hsue MD
Adult Congenital Heart Disease
Associate Professor, Medicine, University of California, San Francisco, School of Medicine
Join to View Full Profile
100 Medical Plaza Driveway Suite 630Los Angeles, CA 90095
Phone+1 310-825-9011
Fax+1 415-206-3872
Dr. Hsue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1999 - 2002
University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1998 - 2028
American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Effect of Raltegravir on Endothelial Function in HIV-Infected Patients Start of enrollment: 2009 Jan 01
- Effect of Maraviroc on Endothelial Function in HIV-Infected Patients Start of enrollment: 2010 Jan 01
- Atherosclerosis in Rheumatoid Arthritis Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity.Saate S Shakil, Priscilla Y Hsue
Circulation. Heart Failure. 2026-04-01 - Rationale, design, and baseline characteristicss of the effect of PCSK9 inhibition on cardiovascular risk in treated HIV infection: EPIC-HIV randomized clinical trial.Matthew S Durstenfeld, Marta Levkova-Clark, Danny Li, Veronica Schaffer, Shady Abohashem
American Heart Journal. 2026-02-28 - Clonal Hematopoiesis in HIV and Atherosclerosis, Arterial Inflammation, and Hematopoietic Activity.Matthew S Durstenfeld, Katherine J Kentoffio, Alexandra E Teng, Shady Abohashem, Danny Li
Medrxiv. 2026-02-09
Journal Articles
- Association of Viral Persistence and Atherosclerosis in Adults with Treated HIV InfectionJeffrey N Martin, Steven G Deeks, Priscilla Y Hsue, JAMA Network Open
- Inflammation, Immunity, and Infection in AtherothrombosisPaul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
- Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Diane Havlir, Clinical Infectious Diseases
Press Mentions
Aha Scientific Sessions: UCLA Health Experts Share New Advances in Heart Failure, Cardio-Oncology, and Arrhythmia CareNovember 7th, 2025
Injectable Medications Prove Effective at Lowering LDL CholesterolJanuary 17th, 2025
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S.September 5th, 2024
Grant Support
- Heart and Lung Outcomes Post-TB (HALO Post-TB)UNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
- REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)UNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









